Ceftazidime-Avibactam for the Treatment of Infections Due to Ceftazidime Resistant Pathogens

NCT01644643 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
345
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer

Collaborators